Abstract
In hematologic malignancies chromosome aberrations generating fusion genes include cryptic deletions. In a patient with acute myeloid leukemia and normal karyo-type we discovered a new cryptic 9q34 deletion and here report the cytogenetic and molecular findings. The 9q34 deletion extends 2.5 megabases and juxtaposes the 5' TAF-I to the 3' CAN producing a TAF-I/CAN fusion gene. TAF-I/CAN transcribes into two fusion proteins bearing either TAF-Ialpha or TAF-Ibeta moieties. We set up molecular assays to monitor the chimeric TAF-Ialpha/CAN and TAF-Ibeta/CAN transcripts which, after hematopoietic stem cell transplantation from an HLA-identical sibling, were no longer detected.
MeSH terms
-
Adult
-
Base Sequence
-
Chromosomal Proteins, Non-Histone / genetics*
-
Chromosome Deletion*
-
Chromosomes, Human, Pair 9*
-
DNA-Binding Proteins
-
Gene Expression Regulation, Neoplastic*
-
Hematopoietic Stem Cell Transplantation
-
Histone Chaperones
-
Humans
-
Leukemia, Myeloid, Acute / genetics*
-
Male
-
Molecular Sequence Data
-
Nuclear Pore Complex Proteins / genetics*
-
Oncogene Proteins, Fusion / genetics*
-
RNA, Messenger / metabolism*
-
Transcription Factors / genetics*
Substances
-
Chromosomal Proteins, Non-Histone
-
DNA-Binding Proteins
-
Histone Chaperones
-
NUP214 protein, human
-
Nuclear Pore Complex Proteins
-
Oncogene Proteins, Fusion
-
RNA, Messenger
-
SET protein, human
-
SET-CAN fusion protein, human
-
Transcription Factors